| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.23 | 1e-06 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.2 | 5e-06 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.18 | 2e-05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.2 | 0.0003 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.17 | 0.0004 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.16 | 0.0008 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.095 | 0.05 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.09 | 0.06 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.093 | 0.07 |